• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Green Mountain Power

Green Mountain Power

  1. PetroFrontier Corp. retains GMP Securities L.P.

    PetroFrontier Corp. retains GMP Securities L.P.

  2. China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014

    China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014

  3. Capstone Nutrition and MusclePharm Sign Strategic Supply Agreements

    Capstone Nutrition and MusclePharm Sign Strategic Supply Agreements

  4. Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc.

    Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc.

  5. Intertek expert invited as lead instructor at Pittcon 2015

    Intertek expert invited as lead instructor at Pittcon 2015

  6. Rich Pharmaceuticals Announces Completion of the Manufacture of RP-323 Study Drug in Connection with Obtaining FDA's Final Approval of The Investigational New Drug (IND) Application For The Treatment ...

    Rich Pharmaceuticals Announces Completion of the Manufacture of RP-323 Study Drug in Connection with Obtaining FDA's Final Approval of The Investigational New Drug (IND) Application For The Treatment of Acute Myelocytic Leukemia

  7. Research and Markets: Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 with Abbott Laboratories, Aurobindo Pharma, Mylan & Teva Pharmaceutical Industries Dominating

    Research and Markets: Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 with Abbott Laboratories, Aurobindo Pharma, Mylan & Teva Pharmaceutical Industries Dominating

  8. THERAVECTYS Obtains Orphan Drug Designation from the European Medicines Agency for Its Lentiviral Vector-Based Therapeutic Vaccine against Adult T-Cell Leukemia and Lymphoma

    THERAVECTYS Obtains Orphan Drug Designation from the European Medicines Agency for Its Lentiviral Vector-Based Therapeutic Vaccine against Adult T-Cell Leukemia and Lymphoma

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.